WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Kelliher, formerly Executive Vice President, Corporate Development and Strategy, has been promoted to Chief Business Officer, and James P. Brady has joined the company as Chief Human Resources Officer. Since joining Ardelyx in March 202 ...

Core Insights - Snowflake has agreed to acquire Crunchy Data for approximately $250 million, enhancing its cloud-based database offerings [1][3] - Crunchy Data specializes in a cloud-hosted version of PostgreSQL, which has gained popularity over MySQL, and offers security and performance enhancements [2] - Crunchy Data generates over $30 million in annualized revenue, indicating a solid financial foundation for the acquisition [3] Company Developments - The acquisition will allow Snowflake to provide early access to a PostgreSQL database service, simplifying data migration and query processes for clients [5] - Snowflake's shares have increased by around 36% this year, reflecting strong market performance and investor confidence [6] - CEO Sridhar Ramaswamy emphasized the company's commitment to supporting clients in the era of agentic AI, indicating a strategic focus on AI-driven solutions [7] Competitive Landscape - Snowflake's acquisition comes in the context of increased competition, as rival Databricks announced its intent to acquire Neon for around $1 billion, also based on PostgreSQL [3][4] - Both companies are leveraging acquisitions to capitalize on corporate spending in AI technologies [4]

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of William “Bill” Conkling as Chief Commercial Officer. He brings more than two decades of experience developing and commercializing novel cancer and rare disease therapeutics to Protara. “It is a pleasure to welcome Bill, a deeply experienced and proven commercial leader,” said Jesse ...

TALLAHASSEE, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- The board of directors of Capital City Bank Group (NASDAQ: CCBG) announced today that Bethany Corum has been named president of Capital City Bank, effective as of July 1, 2025. This historic appointment takes place during the Bank’s landmark 130th anniversary year and marks a significant milestone as Corum becomes the first female president in the history of the Bank. She assumes this role with extensive experience and a deep commitment to championing the ...

NEW HAVEN, Conn., June 2, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and in patients with refractory chronic cough (RCC), today announced that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock. All of the shares in the offering are being offered by ...

Initiation of Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data in 2026 Additional Data from the Ongoing Phase 1b/2 Study of NUC-3373 in Combination with Pembrolizumab Remain on track for 2025 Anticipated Cash Runway Extended into Q4 2026 to Support Key Value-Driving Milestones and Complete the Expansion Study of NUC-7738 EDINBURGH, United Kingdom, June 02, 20 ...

EDISON, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), America’s leading innovator in designing, manufacturing, and providing zinc-based long duration energy storage systems sourced and manufactured in the United States, today announced its participation in an upcoming investor event. Stifel 2025 Boston Cross Sector 1x1 Conference Chief Executive Officer Joe Mastrangelo will attend the Stifel 2025 Boston Cross Sector 1x1 Conference on Tuesday, J ...

Accessibility StatementSkip Navigation The Company currently has nine drill rigs operating as part of its fully funded 70,000-metre drill program for 2025 with seven rigs operating at the Guayabales Project and two rigs turning at the San Antonio Project. Two additional deep capacity rigs are being mobilized to the Guayabales Project to continue testing, at depth, the high-grade Ramp Zone located at the bottom of the Apollo system in early Q3, 2025. The 2025 objectives for the portion of the drilling progra ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Arizona Sonoran Copper Company Inc. (“Arizona Sonoran” or the “Company”) (TSX:ASCU) is pleased to announce that it has entered into an agreement with Scotiabank, as sole bookrunner, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 22,500,000 common shares ...

DUBLIN, June 2, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat presentation at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 10:00 a.m. EDT (3:00 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.About Alkermes plcAlkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neurosc ...